This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Contrary to some narratives of decline, recent data reveals a more nuanced pictureone of evolution, resilience, and an urgent need for continued support. While patient enrollment peaked in 2020, current levels remain significantly higher than when recreational cannabis became legal in 2018. decrease from peak enrollment.
Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. times more likely to achieve their treatment goals with medical cannabis. This gives us baseline measurements that we can track over time.
Cannabis is not a universal cure, but for millions, it provides relief when conventional treatments fail. Unlike many conventional treatments, cannabis offers a level of personalization that sets it apart. Beyond the clichés and outdated stereotypes, the real answer lies in the science—and the stories—of healing.
The enactment of adult-use cannabis legalization laws is not associated with an increase in marijuana-related youth drug treatment admissions, according to data published in the journal Drug and Alcohol Dependence. Our results indicate that RML in Colorado and Washington was not associated with an increase in treatment admissions.
Federal health regulators recently declined to approve the use of the psychedelic drug midomafetamine (3,4-methylenedioxymethamphetamine or MDMA) as a treatment for post-traumatic stress disorder (PTSD), disappointing many advocates who were hopeful for the next breakthrough in the psychedelic therapy movement.
The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management.
There is an absence of clinical data supporting the efficacy of CBD as an antiviral agent, according to a systematic literature review published in the journal Cannabis and Cannabinoid Research. However, this data was based solely on preclinical findings. ” — appears online here.
‘ A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Practice Sites ‘ Takakuwa K M, Sulak D (December 02, 2020). The post Published data on cannabis treatment to reduce opioid usage appeared first on Healer.
The decrim process requires no arrest, no handcuffs, no custody, no court, no jail, no supervision, no treatment, and no permanent record. According to recent data released by ACLU-NJ, marijuana possession arrests have risen 35% in just four years. A constitutional amendment is being considered for 2020.
Yet despite these and other claims , including those spreading on social media , there is as of yet no substantiated clinical data supporting either the prophylactic or therapeutic use of cannabis products in the treatment of COVID-19.
The deadline to submit comments to the agency is Tuesday, June 16, 2020. CDC invites comments specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments. percent in 2016).”
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.
According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. Substance abuse education and treatment programs. General funds.
Researchers from Temple University sought to find out how recreational marijuana legalization in Washington and Colorado influenced adolescent treatment admissions for cannabis. MARIJUANA LEGALIZATION & YOUTH DRUG TREATMENT ADMISSIONS. Researchers Jeremy Mennis and Gerald J.
The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?
This is an example of racial disparity, defined as “the imbalances and incongruities between the treatment of racial groups” by Howard University. In order to do so, they made use of data from 37 states between 2000 and 2019. Additionally, Black Wisconsinites were 4.2
The latter requires extensive vetting , including analyses of the underlying target condition and other related available treatments, conducting a cost benefit analysis from clinical data, as well as strategizing on how drug risks may be identified and mitigated. Collin Peterson (MN 7th District), introduced H.
Many mental health disorders have treatment options, but they aren’t nearly as safe and efficacious as conventional pharmaceuticals or therapies. CSE: MXT) (OTCQB: MXTTF) aims to address these problems by pairing biometric interviews with brainwave data to create a proprietary mental health reference database. (CSE:
Researchers studying the efficacy of marijuana treatments for veterans’ mental health now have access to $20 million in marijuana tax revenue to fund clinical trials. Department of Veteran Affairs’ most recent data. Government revenue collected in recreational marijuana excise taxes totaled $31 million in fiscal year 2020.
A November 2020 report from the Centers for Disease Control and Prevention found far fewer teens going to the hospital for pot as adult-use laws took effect nationwide. Centers for Disease Control, 2020. CDC data aligns with most surveys. The data on this issue is clear, consistent, and available.
All but two of the 45 respondents said they’d consider cannabis as a treatment, with 29 seeking help for sleep disturbances, 27 for emotional complaints, 25 for functional disturbances, and nine for pain. Despite all this, there is a potential biological rationale for the treatment of tinnitus with cannabinoids, the authors explain.
There is very little data to support this idea that Cannabis interferes with sleep architecture in the range of dosing that most people would use,” said Dr. Sulak , a physician who specializes in cannabis care. This was not the case for the men who took part in the study. How cannabis affects men and women differently.
The data that is collected in Releaf App is used for multiple research studies and helps physicians identify what products patients are finding most effective. The goal of the CannaMD /Releaf partnership is to collect and leverage data-backed insights to improve the quality of healthcare for registered medical cannabis patients in Florida.
One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.
Published in the Journal of Medical Internet Research, the fresh data suggests that the cannabinoids found in cannabis, such as THC and CBD , may have potential as a treatment for sleep deprivation. A literature review of existing research suggested that CBD specifically may hold therapeutic potential for the treatment of insomnia.
That seems a hard argument to make, since cannabis has been a major story since the ballot initiative passed in November 2020; you’d think everyone’s had ample time to ponder what legalization would mean. The legislation would expunge misdemeanor convictions and fund substance abuse treatment programs. supreme court. Stay tuned!
loss per share, during the same period in 2020 (after including non-cash share-based compensation expense of $11.4 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021.
HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. This was somewhat less than the nearly 37% decline seen in 2020.
A 2020 study from the University of New Mexico recently unveiled promising results, showing cannabis flowers with high tetrahydrocannabinol (THC) levels may be a helpful remedy for reducing symptoms of depression. Talk to a medical cannabis doctor to determine a good treatment plan for your symptoms.
The cause of legalization in Israel also received an apparent boost back in February, 2020, when then-Prime Minister Benjamin Netanyahu tweeted (at 4:20pm) that he had examined the matter and decided to support the expungement of the records for tens of thousands of Israelis charged with minor cannabis possession charges.
According to the Arkansas Department of Health’s end-of-year fiscal report for 2020 , these were the top qualifying conditions for residents of the Natural State: Condition Number of patients Percentage of total Intractable pain that doesn’t respond to other treatments for more than 6 months 19,728 32.5% Cancer 839 7.8%.
And despite being closed for two months in 2020 due to the COVID-19 public health emergency in Massachusetts, 89 Marijuana Retailers generated $714.1 million over the second year of adult-use sales, from November 2019 to November 2020, while 91 Marijuana Retailers reached a total of $702 million for the full calendar year of 2020.
First, in early March 2020, FDA Commissioner Stephen Hahn issued a statement updating the public on the agency’s work. To that end, the FDA followed up with another piece of public guidance in late April, informing the public that there are currently no approved treatments for COVID-19. Federal Court Litigation.
Eight of the laws passed in 2020 or 2021, and in seven of those states, licensing and tax collections have not yet begun. In the 2019 and 2020 fiscal years, state officials reported that revenue from the 37% cannabis retail tax outpaced alcohol tax revenue, despite the fact that many more adults consume alcohol than cannabis.
One particularly promising area of research is in the treatment of cancer. Cancer patients suffer not only from cancer, but the damaging effects of treatment. Cannabis Cancer Treatments as an Alternative to Opioids. Therefore doctors now consider cannabis as the better treatment option. In some cases opiods work better.
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
This is according to recent data from a report published by Market Research Future (MRT) – a pioneer in market analysis. The report authors noted that THC, on the other hand, is touted as a popular option for alleviating the negative effects of AIDS and cancer treatment.
It’s a non-psychoactive compound found in marijuana and hemp plants and used for treatment of certain medical problems. Curren hopes to expand internationally by 2020. “A State lawmakers in Nebraska just formed a campaign committee to put a medical cannabis initiative to voters in 2020. It’s not just the U.S.
” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial. SOURCE InMed Pharmaceuticals Inc.
Currently, the only treatment for cancer cells includes filling your body with such potent chemicals that the cancer patients need additional medication to alleviate the consequences of putting those chemicals in your body. The post Veriheal’s Favorite Cannabis Research Studies of 2020 appeared first on Cannabis Central.
The global chronic pain treatment market is predicted to progress at a CAGR of 6.5% from 2020 to 2030 and generate revenue of $151.7 It is an honour and privilege to be in the position to use novel psychedelic treatments to solve the complex puzzle that is chronic pain. billion in 2030. The purchase price of CDN$2,500,000.00
In 2020, founders Daniel Goldberg , Tim Schlidt and Tony Eisenberg partnered to form Palo Santo, and formally launched the venture capital fund in 2021. Supported by a rapidly growing body of evidence and strong FDA support, psychedelic-assisted treatments represent a paradigm shift in mental healthcare. Tweet this.
million in 2020, having declined at a compound annual growth rate (CAGR) of -3.2% million in 2020 to $474,364.8 Create regional and country strategies on the basis of local data and analysis. Outperform competitors using forecast data and the drivers and trends shaping the market. since 2015. from 2025 and reach $618,392.6
And data compiled by the Financial Crimes Enforcement Network (FinCEN) show that more and more financial institutions are serving the industry, even without federal legislation on the practice. And researchers at the University of Georgia will be studying medical cannabis as a treatment for chronic pain.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content